Welcome to LookChem.com Sign In|Join Free

CAS

  • or

126614-05-9

Post Buying Request

126614-05-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1,3-Dioxolane-4-methanaminium,2-heptadecyl-N-(3-hydroxypropyl)-N,N-dimethyl-, bromide (1:1)

    Cas No: 126614-05-9

  • No Data

  • No Data

  • No Data

  • Chemical Co.Ltd
  • Contact Supplier

126614-05-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 126614-05-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,6,6,1 and 4 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 126614-05:
(8*1)+(7*2)+(6*6)+(5*6)+(4*1)+(3*4)+(2*0)+(1*5)=109
109 % 10 = 9
So 126614-05-9 is a valid CAS Registry Number.

126614-05-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name (2-heptadecyl-1,3-dioxolan-4-yl)methyl-(3-hydroxypropyl)-dimethylazanium,bromide

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:126614-05-9 SDS

126614-05-9Downstream Products

126614-05-9Relevant articles and documents

Quaternary amine containing ether or ester lipid derivatives and therapeutic compositions

-

, (2008/06/13)

Quaternary amine-containing ether lipid analogs of the formula are disclosed. R1 represents a hydrophobic group and R2 represents the backbone of the molecule, with the quaternary amine being linked directly to the backbone. Pharmaceutical compositions including these compounds and methods of combating tumors with these compounds are disclosed. Also disclosed is a method of combating viral infections with both these compounds and ET-18-OMe and its analogs.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 126614-05-9